Inflammation-targeting polyamine nanomedicines for the treatment of ulcerative colitis-Reference-Cited by-同舟云学术

Inflammation-targeting polyamine nanomedicines for the treatment of ulcerative colitis

Published:2023 Issue:18 Volume:11 Page:4005-4013
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Nishiguchi Akihiro¹^ORCID,Taguchi Tetsushi¹^ORCID

Affiliation:

1. Polymers and Biomaterials Field, Research Center for Functional Materials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan

Abstract

Orally administered anti-inflammatory polyamine-based nanomedicines are presented. Inflammation-targeting, radical scavenging, and biocompatible nanomedicines may serve as therapeutic drugs for inflammatory diseases.

Funder

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2023/TB/D3TB00424D

Reference33 articles.

1. Toll-like receptors in inflammatory bowel diseases: A decade later

2. Innate immune mechanisms of colitis and colitis-associated colorectal cancer